We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

80 hedge funds and large institutions have $27.8M invested in Tandem Diabetes Care in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 14

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

7% more funds holding

Funds holding: 75 → 80 (+5)

6% more capital invested

Capital invested by funds: $26.2M → $27.8M (+$1.56M)

0.71% more ownership

Funds ownership: 3.98% → 4.69% (+0.71%)

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
1.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
28
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCM
Frontier Capital Management
Massachusetts
+$8.33M
2
WA
Wasatch Advisors
Utah
+$5.13M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.5M
4
BlackRock
BlackRock
New York
+$2.23M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.11M

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$591K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$316K
3
Renaissance Technologies
Renaissance Technologies
New York
-$302K
4
FA
FDx Advisors
Illinois
-$210K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$147K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$1K +$1.77K +81 New
AG
77
Advisor Group
Arizona
$1K +$2.19K +100 New
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$391 -$1.09K -50 -60%
EAM
79
Eventide Asset Management
Massachusetts
– -$591K -27,500 Closed
FA
80
FDx Advisors
Illinois
– -$210K -9,775 Closed
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
– -$147K -6,839 Closed
TCIM
82
TIAA CREF Investment Management
New York
– -$127K -5,888 Closed
ARTA
83
A.R.T. Advisors
New York
– -$116K -5,410 Closed
TC
84
TFS Capital
Pennsylvania
– -$106K -4,917 Closed
Citadel Advisors
85
Citadel Advisors
Florida
– -$81K -3,778 Closed
Goldman Sachs
86
Goldman Sachs
New York
– -$69K -3,207 Closed
SKK
87
Shepherd Kaplan Krochuk
Massachusetts
– -$62K -2,887 Closed
TA
88
Teachers Advisors
New York
– -$61K -2,824 Closed
BIM
89
Bogle Investment Management
Massachusetts
– -$59K -2,763 Closed
AQR Capital Management
90
AQR Capital Management
Connecticut
– -$57K -2,665 Closed
OAM
91
Oppenheimer Asset Management
New York
– +$44 +2 New
PNC Financial Services Group
92
PNC Financial Services Group
Pennsylvania
– +$219 +10 +500%
AIM
93
Acrospire Investment Management
Illinois
– +$721 +33 New
1 2 3
4

TNDM Hedge Fund Activity: Q1 2017 in Review

80 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2017, worth a combined $27.8M — up 5.9% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new TNDM positions and 12 closed out — a net gain of 9 holders — while 28 added to existing stakes and 14 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $8.33M. The largest seller was Eventide Asset Management, exiting entirely with an estimated $591K sold.

  • 80 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2017, up from 75 in Q4 2016.
  • Funds reported $27.8M of Tandem Diabetes Care stock for Q1 2017, up 5.9% quarter-over-quarter.
  • 21 funds opened new Tandem Diabetes Care positions in Q1 2017 and 12 closed out, a net change of +9 holders.
  • The largest Tandem Diabetes Care buyer in Q1 2017 was Frontier Capital Management, an estimated $8.33M added.
  • The largest Tandem Diabetes Care seller in Q1 2017 was Eventide Asset Management, an estimated $591K sold.

Based on aggregated 13F filings for Q1 2017.